Semiconductor designer Lattice Semiconductor (NASDAQ:LSCC) met Wall Streets revenue expectations in Q3 CY2025, with sales up ...

WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial.

On October 30, 2025, the Special Rapporteur on the situation of human rights in Afghanistan, Richard Bennett, in his report ...

Crogl, the cybersecurity risk management company, today announced that it has received a patent (US12277177B1) that enables its knowledge engine to traverse, interrogate and build an understanding of ...

This special report focuses on India's escalating air pollution crisis through the eyes of 'Warrior Moms,' a citizen-led ...

Get key insights from Modine’s Q2 2026 earnings: accelerating data center growth, expanded capacity, strong outlook, and management’s confident execution.

Ascendis Pharma A/S (Nasdaq: ASND) today announced that its data showing sustained improvements in renal function, continued ...

Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen (HBsAg). Their efficacy and safety in the treatment of chronic hepatitis D ...

Introduction The Abraham Accords began in 2020 as a normalization initiative between Israel, the United Arab Emirates, and Bahrain, later joined by Morocco and Sudan .

Agentic AI systems promise to enhance human productivity by automating complex tasks through intelligent reasoning.

Penumbra (NYSE:PEN) announced additional results from its STORM-PE trial of computer-assisted vacuum thrombectomy (CAVT).

Microarrays have set the stage for an explosion of large-scale expression data, driven by a diversity of genome sequencing projects. The technology has already demonstrated its applications in ...